EMEA (Europe, Middle East and Africa) Antibody Drugs Market Report 2017

October 2017 | 106 pages | ID: EB2884EB76EPEN
QYResearch

Abstracts

In this report, the EMEA Antibody Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Antibody Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Antibody Drugs market competition by top manufacturers/players, with Antibody Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis
• Amgen
• Bristol-Myers Squibb
• F. Hoffmann-La Roche
• Johnson & Johnson
• AbbVie
• Eli Lilly

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• Monoclonal Antibodies
• Antibody-Drug Conjugates
• Polyclonal Antibodies

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Antibody Drugs for each application, including

• Central Nervous System (CNS) Disorders
• Cancers
• Autoimmune Disorders
• Cardiovascular Diseases

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Antibody Drugs Market Report 2017

1 ANTIBODY DRUGS OVERVIEW

1.1 Product Overview and Scope of Antibody Drugs
1.2 Classification of Antibody Drugs
  1.2.1 EMEA Antibody Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Antibody Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Monoclonal Antibodies
  1.2.4 Antibody-Drug Conjugates
  1.2.5 Polyclonal Antibodies
1.3 EMEA Antibody Drugs Market by Application/End Users
  1.3.1 EMEA Antibody Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Central Nervous System (CNS) Disorders
  1.3.3 Cancers
  1.3.4 Autoimmune Disorders
  1.3.5 Cardiovascular Diseases
1.4 EMEA Antibody Drugs Market by Region
  1.4.1 EMEA Antibody Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Antibody Drugs (2012-2022)
  1.5.1 EMEA Antibody Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Antibody Drugs Revenue and Growth Rate (2012-2022)

2 EMEA ANTIBODY DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Antibody Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Antibody Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Antibody Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Antibody Drugs Sale Price by Players (2012-2017)
2.2 EMEA Antibody Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Antibody Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Antibody Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Antibody Drugs Sale Price by Type (2012-2017)
2.3 EMEA Antibody Drugs (Volume) by Application
2.4 EMEA Antibody Drugs (Volume and Value) by Region
  2.4.1 EMEA Antibody Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Antibody Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Antibody Drugs Sales Price by Region (2012-2017)

3 EUROPE ANTIBODY DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Antibody Drugs Sales and Value (2012-2017)
  3.1.1 Europe Antibody Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Antibody Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Antibody Drugs Sales and Market Share by Type
3.3 Europe Antibody Drugs Sales and Market Share by Application
3.4 Europe Antibody Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Antibody Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Antibody Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Antibody Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Antibody Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Antibody Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Antibody Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Antibody Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Antibody Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ANTIBODY DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Antibody Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Antibody Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Antibody Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Antibody Drugs Sales and Market Share by Type
4.3 Middle East Antibody Drugs Sales and Market Share by Application
4.4 Middle East Antibody Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Antibody Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Antibody Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Antibody Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Antibody Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Antibody Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Antibody Drugs Sales and Growth Rate (2012-2017)

5 AFRICA ANTIBODY DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Antibody Drugs Sales and Value (2012-2017)
  5.1.1 Africa Antibody Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Antibody Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Antibody Drugs Sales and Market Share by Type
5.3 Africa Antibody Drugs Sales and Market Share by Application
5.4 Africa Antibody Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Antibody Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Antibody Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Antibody Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Antibody Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Antibody Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Antibody Drugs Sales and Growth Rate (2012-2017)

6 EMEA ANTIBODY DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antibody Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Antibody Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Amgen
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Antibody Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Amgen Antibody Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bristol-Myers Squibb
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Antibody Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bristol-Myers Squibb Antibody Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 F. Hoffmann-La Roche
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Antibody Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 F. Hoffmann-La Roche Antibody Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Johnson & Johnson
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Antibody Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Johnson & Johnson Antibody Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AbbVie
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Antibody Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AbbVie Antibody Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Eli Lilly
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Antibody Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Eli Lilly Antibody Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 ANTIBODY DRUGS MANUFACTURING COST ANALYSIS

7.1 Antibody Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antibody Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antibody Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antibody Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ANTIBODY DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Antibody Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Antibody Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Antibody Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Antibody Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Antibody Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Antibody Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Antibody Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Antibody Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Antibody Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Antibody Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antibody Drugs
Figure EMEA Antibody Drugs Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Antibody Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Monoclonal Antibodies Product Picture
Figure Antibody-Drug Conjugates Product Picture
Figure Polyclonal Antibodies Product Picture
Figure EMEA Antibody Drugs Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Antibody Drugs by Application in 2016
Figure Central Nervous System (CNS) Disorders Examples
Table Key Downstream Customer in Central Nervous System (CNS) Disorders
Figure Cancers Examples
Table Key Downstream Customer in Cancers
Figure Autoimmune Disorders Examples
Table Key Downstream Customer in Autoimmune Disorders
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure EMEA Antibody Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Antibody Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Antibody Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Antibody Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Antibody Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Antibody Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Antibody Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Antibody Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Antibody Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Antibody Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Antibody Drugs Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Antibody Drugs Sales Share by Players (2012-2017)
Figure 2016 Antibody Drugs Sales Share by Players
Figure 2017 Antibody Drugs Sales Share by Players
Figure EMEA Antibody Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Antibody Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Antibody Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Antibody Drugs Revenue Share by Players
Table 2017 EMEA Antibody Drugs Revenue Share by Players
Table EMEA Antibody Drugs Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Antibody Drugs Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Antibody Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Antibody Drugs by Type (2012-2017)
Figure EMEA Antibody Drugs Sales Market Share by Type (2012-2017)
Table EMEA Antibody Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Antibody Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antibody Drugs by Type in 2016
Table EMEA Antibody Drugs Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Antibody Drugs Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Antibody Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Antibody Drugs by Application (2012-2017)
Figure EMEA Antibody Drugs Sales Market Share by Application in 2016
Table EMEA Antibody Drugs Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Antibody Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Antibody Drugs by Region (2012-2017)
Figure EMEA Antibody Drugs Sales Market Share in 2016
Table EMEA Antibody Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Antibody Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Antibody Drugs by Region (2012-2017)
Figure EMEA Antibody Drugs Revenue Market Share Regions in 2016
Table EMEA Antibody Drugs Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Antibody Drugs Revenue and Growth Rate (2012-2017)
Table Europe Antibody Drugs Sales (K Pcs) by Type (2012-2017)
Table Europe Antibody Drugs Market Share by Type (2012-2017)
Figure Europe Antibody Drugs Market Share by Type in 2016
Table Europe Antibody Drugs Sales (K Pcs) by Application (2012-2017)
Table Europe Antibody Drugs Market Share by Application (2012-2017)
Figure Europe Antibody Drugs Market Share by Application in 2016
Table Europe Antibody Drugs Sales (K Pcs) by Countries (2012-2017)
Table Europe Antibody Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Antibody Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Antibody Drugs Sales Market Share by Countries in 2016
Table Europe Antibody Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Antibody Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Antibody Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Antibody Drugs Revenue Market Share by Countries in 2016
Figure Germany Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Antibody Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Antibody Drugs Sales (K Pcs) by Type (2012-2017)
Table Middle East Antibody Drugs Market Share by Type (2012-2017)
Figure Middle East Antibody Drugs Market Share by Type (2012-2017)
Table Middle East Antibody Drugs Sales (K Pcs) by Applications (2012-2017)
Table Middle East Antibody Drugs Market Share by Applications (2012-2017)
Figure Middle East Antibody Drugs Sales Market Share by Application in 2016
Table Middle East Antibody Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Antibody Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Antibody Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Antibody Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Antibody Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Antibody Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Antibody Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Antibody Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Antibody Drugs Sales (K Pcs) by Type (2012-2017)
Table Africa Antibody Drugs Sales Market Share by Type (2012-2017)
Figure Africa Antibody Drugs Sales Market Share by Type (2012-2017)
Figure Africa Antibody Drugs Sales Market Share by Type in 2016
Table Africa Antibody Drugs Sales (K Pcs) by Application (2012-2017)
Table Africa Antibody Drugs Sales Market Share by Application (2012-2017)
Figure Africa Antibody Drugs Sales Market Share by Application (2012-2017)
Table Africa Antibody Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Antibody Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Antibody Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Antibody Drugs Sales Market Share by Countries in 2016
Table Africa Antibody Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Antibody Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Antibody Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Antibody Drugs Revenue Market Share by Countries in 2016
Figure South Africa Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Novartis Antibody Drugs Basic Information List
Table Novartis Antibody Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis Antibody Drugs Sales Market Share in EMEA (2012-2017)
Figure Novartis Antibody Drugs Revenue Market Share in EMEA (2012-2017)
Table Amgen Antibody Drugs Basic Information List
Table Amgen Antibody Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Amgen Antibody Drugs Sales Market Share in EMEA (2012-2017)
Figure Amgen Antibody Drugs Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Antibody Drugs Basic Information List
Table Bristol-Myers Squibb Antibody Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Antibody Drugs Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb Antibody Drugs Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche Antibody Drugs Basic Information List
Table F. Hoffmann-La Roche Antibody Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Antibody Drugs Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Antibody Drugs Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Antibody Drugs Basic Information List
Table Johnson & Johnson Antibody Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Johnson & Johnson Antibody Drugs Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Antibody Drugs Revenue Market Share in EMEA (2012-2017)
Table AbbVie Antibody Drugs Basic Information List
Table AbbVie Antibody Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure AbbVie Antibody Drugs Sales Market Share in EMEA (2012-2017)
Figure AbbVie Antibody Drugs Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Antibody Drugs Basic Information List
Table Eli Lilly Antibody Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Antibody Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Eli Lilly Antibody Drugs Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Antibody Drugs Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody Drugs
Figure Manufacturing Process Analysis of Antibody Drugs
Figure Antibody Drugs Industrial Chain Analysis
Table Raw Materials Sources of Antibody Drugs Major Manufacturers in 2016
Table Major Buyers of Antibody Drugs
Table Distributors/Traders List
Figure EMEA Antibody Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Antibody Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Antibody Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Antibody Drugs Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Antibody Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Antibody Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Antibody Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Antibody Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Antibody Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Antibody Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Antibody Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Antibody Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Antibody Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Antibody Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Antibody Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Antibody Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Antibody Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Antibody Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Antibody Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Antibody Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Antibody Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Antibody Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Antibody Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources